Remove Big Data Remove Clinical Research Remove Pharma Companies Remove Research
article thumbnail

Synthetic control arms in clinical trials: Making it happen

pharmaphorum

Across the industry, pharma companies are turning to AI and real-world data to address many of the challenges of running clinical trials. David Clifton is professor of clinical machine learning in the Department of Engineering Science of the University of Oxford. About the panel.

article thumbnail

EMA pilot will see if clinical trial data should be digested ‘raw’

pharmaphorum

That could include original observations and measurements of clinical study participants, such as lab results, imaging data, and patient medical charts. It has been quick to give reassurance that any analysis of patient data will comply with the EU’s data protection requirements.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

5 Top Emerging Pharmacovigilance Startups Impacting The Industry

Cloudbyz

Using our StartUs Insights Platform , covering 1.116.000+ startups & emerging companies, we looked at innovation in the field of pharma. For this research, we identified 164 relevant solutions and picked 5 to showcase below. Clinical trials for different kinds of drugs often mandate differences in the patient pools.

article thumbnail

Creating an effective patient engagement set of practices that is enduring and future-proof

pharmaphorum

The ‘PEP Talks’ monthly e-newsletter has approaching 50 pharma companies as subscribers and the inaugural ‘Patient Engagement Day’ on September 01 st achieved an inspirational number of downloads of toolkits for ways to ‘Amplify the Patient Voice’ as the launch theme. Will pharma listen, and is this even their role to do so?